⌘K

Login Start Free

Home/Filings/4/0001213900-25-001166

4//SEC Filing

Gabay Avraham 4

Accession 0001213900-25-001166

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:10 PM ET

Size

5.0 KB

Accession

0001213900-25-001166

Insider Transaction Report

Form 4

Period: 2025-01-02

ORAMED PHARMACEUTICALS INC.ORMP

Chief Financial Officer

Transactions

Award
Common Stock
2025-01-02+188,000→ 358,040 total

Footnotes (1)

[F1]Represents Restricted Stock Units ("RSUs") that will vest in quarterly installments of approximately 15,666 over a three year period starting January 1, 2025. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001777328

Filing Metadata

Form type: 4
Filed: Jan 5, 7:00 PM ET
Accepted: Jan 6, 4:10 PM ET
Size: 5.0 KB

View on SEC.gov